Catalyst Event
Viatris Inc (VTRS) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
7/30/2026, 12:00:00 AM
The FDA has set a PDUFA target action date of July 30, 2026, for a decision on Viatris's investigational low-dose estrogen contraceptive patch, Xulane LO, which is expected. Market impact is estimated to be medium given the significance of FDA approvals for pharmaceutical pipelines.
Korean Translation
FDA가 비아트리스의 연구용 저용량 에스트로겐 피임 패치인 줄란 로(Xulane LO)에 대한 PDUFA 목표 심사 완료일은 2026년 7월 30일로 예정됨. 신약 승인이 파이프라인에 미치는 중요성을 고려할 때 시장 영향은 중간 수준일 것으로 예상됨.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day 2026 is scheduled for 2026-09-16; this event is estimated to have a ≥1% price impact, scheduled.
9/16/2026, 12:00:00 AM
Roblox Corp (RBLX) · Earnings Release
Roblox is scheduled to release its Q2 2026 earnings report on 2026-08-11. Low importance is estimated as date announcements have minimal impact, scheduled
8/11/2026, 12:00:00 AM
Kratos Defense & Security Solutions Inc (KTOS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled. Market impact is estimated at Medium as earnings releases typically result in 5-10% price movement.
8/6/2026, 12:00:00 AM
Curtiss-Wright Corp (CW) · Earnings Release
Q2 2026 earnings release expected.
8/5/2026, 12:00:00 AM
Occidental Petroleum Corp (OXY) · Earnings Release
Occidental Petroleum is expected to report its Q2 2026 earnings results around August 5, 2026, based on historical patterns expected.
8/5/2026, 12:00:00 AM
Masco Corporation (MAS) · Earnings Release
Masco's Q2 2026 earnings release is scheduled for July 30, 2026. Estimated 5% impact based on historical volatility during earnings periods expected.
7/30/2026, 12:00:00 AM